Altria Group Inc. released its latest quarterly earnings, driving interest among investors and analysts alike. The company's revenue fell short of analyst predictions, resulting in a mixed market reaction. Significant drivers contributing to this outlook include ongoing litigation. The future for

Breaking: Lilly Partners With US Firms to Make Mounjaro, Boost Supply Eli Lilly, now the world's most valuable healthcare company by market capitalization, has seen its shares soar 62.5% this year due to high demand for their d